The upcoming year could bring higher premiums for Medicare Part D drug coverage as subsidies provided to insurers are set to conclude. This change could impact millions of beneficiaries, potentially leading to increased costs in 2027.
The Inflation Reduction Act of 2022 introduced a cap on out-of-pocket drug spending for Medicare patients. Starting in 2025, this cap was set at $2,000. It also altered the financial responsibilities of insurers for drug payments. Consequently, patients might spend less at pharmacies but insurers would face higher costs.
Initially, insurers faced uncertainty about their future expenses and premium levels. To assist in their adjustment, the Biden administration provided temporary subsidies under a demonstration project intended to stabilize premiums until 2027. However, these subsidies are now ending a year earlier than planned.
“The Biden admin gave BILLIONS of taxpayer money DIRECTLY to Big Insurance Companies,”stated Dr. Mehmet Oz, who oversees the Centers for Medicare and Medicaid, on the social media platform X. “This is unacceptable.”
The Government Accountability Office reported that these subsidies were projected to amount to $9.8 billion in 2025 and 2026. In the same year, about 23 million people were enrolled in standalone Medicare Part D drug plans.
Dr. Oz indicated that the subsidies are no longer essential, estimating most Medicare beneficiaries may see premiums increase by less than $10 next year. However, Juliette Cubanski of KFF warns the rise could be greater. The current average premium for standalone drug plans is approximately $36, and without the subsidies, seniors might face nearly 50% higher premiums.
Details about the exact financial impact await further information from CMS expected later in the year. Concerns arise from Stacie Dusetzina at Vanderbilt University, who notes that while subsidies were never meant as a long-term solution, their removal is worrisome. Traditional Medicare plans, as opposed to Medicare Advantage plans with more flexibility, will feel the greatest impact.
Dusetzina hints that Project 2025, influenced by the Heritage Foundation, aims to encourage a shift from traditional Medicare to Medicare Advantage. If traditional plans become costly, patients might opt for Medicare Advantage despite potential drawbacks such as limited provider networks.
She emphasizes the importance of considering long-term health needs before switching plans, as changes could affect overall health care access and cost management.